Compositions and methods for treating cancer

Details for Australian Patent Application No. 2004226338 (hide)

Owner Threshold Pharmaceuticals, Inc.

Inventors Duan, Jian-Xin; Matteucci, Mark; Rao, Photon

Agent Spruson & Ferguson

Pub. Number AU-B-2004226338

PCT Pub. Number WO2004/087075

Priority 60/458,845 28.03.03 US; 60/465,281 21.04.03 US

Filing date 29 March 2004

Wipo publication date 14 October 2004

Acceptance publication date 19 May 2011

International Classifications

C07D 233/02 (2006.01) Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

A61K 31/415 (2006.01) - 1,2-Diazoles

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 35/00 (2006.01) Antineoplastic agents

C07D 401/00 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/087075 Priority application(s): WO2004/087075

19 May 2011 Application Accepted

  Published as AU-B-2004226338

8 September 2011 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 03 Aug 2011. Address for service in Australia - Spruson & Ferguson Level 35 St Martins Tower 31 Market Street Sydney NSW 2000

12 January 2012 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 03 Aug 2011

19 January 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004226343-Process for the staining of sperm

2004226337-Process for making substituted pyrazoles